SCHEMBL30042811

SCHEMBL30042811

CN1C(=O)CCC(N2C(=O)c3ccc(N4CCN(CC(=O)O)CC4)cc3C2=O)C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 5/20 0.47
▸ IRAK1 P51617 1/20 0.45
▸ IRAK3 Q9Y616 1/20 0.45
▸ ALOX15 P16050 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ HPGDS O60760 2/20 0.39
▸ S1PR1 P21453 1/20 0.39
▸ EGFR P00533 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ KIF11 P52732 3/20 0.38
▸ MMP1 P03956 1/20 0.37
▸ MMP9 P14780 1/20 0.37
▸ ITGB3 P05106 1/20 0.36
▸ ITGA2B P08514 1/20 0.36
▸ DDB1 Q16531 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26139423 1.00 CRBN (0.47) CRBNIRAK1IRAK3ALOX15MEN1
SCHEMBL30996469 0.93 IRAK1 (0.48) CRBNIRAK1IRAK3ALOX15MEN1
SCHEMBL29129961 0.89 IRAK1 (0.47) CRBNIRAK1IRAK3ALOX15MEN1
SCHEMBL27176453 0.88 CRBN (0.48) CRBNIRAK1IRAK3ALOX15MEN1
SCHEMBL29522052 0.87 CRBN (0.46) CRBNIRAK1IRAK3ALOX15MEN1
SCHEMBL29522041 0.87 CRBN (0.46) CRBNIRAK1IRAK3ALOX15MEN1
SCHEMBL31547260 0.83 CRBN (0.44) CRBNIRAK1IRAK3ALOX15MEN1
SCHEMBL30962345 0.82 CRBN (0.46) CRBNIRAK1IRAK3ALOX15MEN1
SCHEMBL24501060 0.82 CRBN (0.54) CRBNIRAK1IRAK3ALOX15MEN1
SCHEMBL29648286 0.82 CRBN (0.54) CRBNIRAK1IRAK3ALOX15MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4107158-A1 BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF Nurix Therapeutics, Inc. (US) 2022-12-28 — — EP disclosed
CN-115335381-A Bifunctional degradants of interleukin-1 receptor-associated kinase and therapeutic uses thereof 新锐思生物制药股份有限公司 2022-11-11 — — CN disclosed
Send feedback